Postmenopausal Hormone Therapy and the Risk for Uterine Cancers
نویسندگان
چکیده
.................................................................................................................... 8 INTRODUCTION .......................................................................................................... 10 REVIEW OF THE LITERATURE ................................................................................ 11 Uterus ............................................................................................................. 11 Endocrine aspects of carcinogenesis ............................................... 12 Endometrial cancer ....................................................................................... 13 Incidence .......................................................................................... 14 Diagnosis .......................................................................................... 15 Risk factors ....................................................................................... 15 Uterine sarcoma ............................................................................................. 16 Incidence .......................................................................................... 17 Diagnosis .......................................................................................... 18 Risk factors ....................................................................................... 18 Cervical cancer .............................................................................................. 19 Screening and diagnosis ................................................................... 19 Incidence .......................................................................................... 21 Risk factors ....................................................................................... 22 Postmenopausal hormone therapies ............................................................ 24 Estrogen-only ................................................................................... 24 Estrogen-progestagen therapy ......................................................... 25 Tibolone ............................................................................................ 26 Route of administration .................................................................... 26 Other modalities ............................................................................... 26 Effects of postmenopausal hormone therapy ................................... 27
منابع مشابه
Onm-1: Imaging in Abnormal Uterine Bleeding
Abnormal uterine bleeding is any bleeding from the uterus other than normal monthly period. Having extremely heavy bleeding during period can also be considered abnormal uterine bleeding. Dysfunctional uterine bleeding (DUB) is heavy or irregular menstrual bleeding that is not caused by an underlying anatomical abnormality, such as a fibroid, lesion, or tumor. DUB is the most common type of abn...
متن کاملDoes short-term estrogen therapy produce lasting benefits in brain?
The question of whether estrogen therapy should be used in postmenopausal women is a topic filled with controversy and debate. In vitro and animal studies clearly show that estrogens (most often 17 -estradiol) are neuroprotective (1), can enhance hippocampal and cortical function (2), improve cognitive performance (3), and prevent or reduce age-related cognitive decline (4, 5). Estrogen therapy...
متن کاملRole of progestogen in hormone therapy for postmenopausal women: position statement of The North American Menopause Society.
OBJECTIVE To create an evidence-based position statement regarding the role of progestogen in postmenopausal hormone therapy (estrogen plus a progestogen, or EPT) for the management of menopause-related symptoms. DESIGN NAMS followed the general principles established for evidence-based guidelines to create this document. Clinicians and researchers acknowledged to be experts in the field of p...
متن کاملSerum vitamin A status in women users of lowdose oral contraceptives and in postmenopausal women taking hormone replacement therapy.
Background: One of the most important nonenzymatic antioxidant defense systems is vitamin A, and is considered as an important dietary agent for reducing cardiovascular diseases. Objective: The objective of this study was to investigate the serum vitamin A status in women who used low-dose oral contraceptives (OCs) containing 0.15 mg levonorgestrol and 0.03 mg ethinyl estradiol and also in...
متن کاملVitex Agnus Castus Extract Improves Learning and Memory and Increases the Transcription of Estrogen Receptor α in Hippocampus of Ovariectomized Rats
Introduction: Lower level of estrogen hormone is considered as an important factor for loss of learning and memory in postmenopausal women. Although estrogen replacement therapy is used for compensation, but long-term usage of estrogen is associated with a higher risk of hormonedependent cancers. Phytoestrogens, due to fewer side effects, have been proposed to prevent menopause-related co...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2012